1. 105446

  2. FUJIFILM Cellular Dynamics and Lonza Agree to Expand the Availability and Use of Induced Pluripotent Stem Cell Technology

    FUJIFILM Cellular Dynamics grants Lonza a non-exclusive right to use their patents related to iPSC generation, including episomal vectors and reprogramming factors, for development and clinical manufacture of iPSC lines for cell therapies Lonza grants FUJIFILM Cellular Dynamics expanded use of its non-exclusive license to its innovative Nucleofector™ technology The agreement enables drug developers to leverage both companies expertise and...
  3. 105567

  4. 105467

  5. 105298

  6. 105465

  7. 105458

  8. A New Validated Human iPSC-Derived Cardiomyocyte Line for Diversification of Donor Responses in Drug Discovery and Safety Pharmacology Studies

    Cardiomyocytes derived from human induced pluripotent stem cells (iPSC) are a reliable and critical in vitro cellular model for drug-induced cardiotoxicity and drug discovery. To complement our gold standard iCell® Cardiomyocytes2, 01434, we developed iCell Cardiomyocytes2, 11713 from an alternative donor iPSC (termed 11713). This iPSC line was generated from blood cells donated by an apparently healthy normal female donor (age...
  9. 105463

  10. Cell and Gene Meeting on the Mesa

    Cell and Gene Meeting on the Mesa
    The Cell & Gene Meeting on the Mesa is a three-day conference combining discussions between senior executives and top decision-makers in the industry. The program also includes 80+ presentations by the field’s most promising companies and extensive one-on-one partnering capabilities.

Items 1 to 10 of 949 total